Bagsværd, 5 November, 2025 - Financial report for the period 1 January 2025 to 30 September 2025                                                                                                                      Operating profit increased by 5% in Danish kroner and 10% at constant exchange rates (CER) to DKK 95.9 billion, impacted by one-off restructuring costs of around DKK 9 billion related to the company-wide transformation with the aim of streamlining Novo Nordisk's operations to reinvest for growth. ...